Terns Pharmaceuticals, Inc. (TERN)

NasdaqGS - NasdaqGS Precio en tiempo real. Divisa en USD

Añadir a la lista de favoritos

6,00

+0,14

(+2,39%)

Al cierre: 04:00PM EDT

6,00

0,00

(0,00%)

Después del cierre:

04:02PM EDT

Accionistas principales

Lista de personas con información privilegiada

Transacciones de accionistas miembros de la empresa

Divisa en USD

Compras de personas con información privilegiada de los 6 últimos meses	Acciones	Trans
Compras	228.243	5
Ventas	420.663	1
Cuotas netas adquiridas (vendidas)	-192.420	6
Acciones de persona con información privilegiada totales	1,15M	N/A
% de acciones netas adquiridas (vendidas)	-14,30%	N/A

Compras institucionales netas del trimestre anterior al último trimestre	Acciones
Cuotas netas adquiridas (vendidas)	N/A
% de cambio en la posesión de acciones institucionales	N/A

Transacciones comunicadas por la persona con información privilegiada: últimos dos años

Persona con información privilegiada	Transacción	Tipo	Valor	Fecha	Acciones
VIVO OPPORTUNITY LLC Beneficial Owner of more than 10% of a Class of Security	Sale at price 6.20 - 6.99 per share.	Indirecto	2.796.859	03 abr 2024	420.663
YOON SEOKHO BRYAN Chief Operating Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	23 ene 2024	68.750
VIGNOLA MARK J. Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	23 ene 2024	68.750
QUIGLEY JILL M. Officer and Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	23 ene 2024	15.000
QUIRK ERIN M.D. Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	23 ene 2024	75.000
YOON SEOKHO BRYAN Chief Operating Officer	Purchase at price 3.78 per share.	Directo	2.809	30 nov 2023	743
QUIGLEY JILL M. Officer and Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	15 nov 2023	15.000
SUNDARAM SENTHIL VEL Chief Executive Officer	Purchase at price 10.61 per share.	Directo	22.398	31 may 2023	2.111
YOON SEOKHO BRYAN Chief Operating Officer	Purchase at price 10.61 per share.	Directo	106.068	31 may 2023	9.997
GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 7.25 per share.	Indirecto	1.000.000	23 dic 2022	137.931
ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 7.25 per share.	Indirecto	1.000.000	23 dic 2022	137.931
LU HONGBO B Director	Purchase at price 7.25 per share.	Indirecto	5.499.995	23 dic 2022	758.620
VIVO OPPORTUNITY LLC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 7.25 per share.	Indirecto	5.499.995	23 dic 2022	758.620
SUNDARAM SENTHIL VEL Chief Executive Officer	Purchase at price 7.77 per share.	Directo	23	30 nov 2022	3
YOON SEOKHO BRYAN Chief Operating Officer	Purchase at price 7.77 per share.	Directo	23	30 nov 2022	3
VIGNOLA MARK J. Chief Financial Officer	Purchase at price 7.77 per share.	Directo	23	30 nov 2022	3
LAV BIOSCIENCES FUND V LP Beneficial Owner of more than 10% of a Class of Security	Sale at price 5.50 per share.	Indirecto	8.250.000	23 nov 2022	1.500.000
LU HONGBO B Director	Purchase at price 3.60 per share.	Indirecto	2.160.000	07 sept 2022	600.000
VIVO OPPORTUNITY LLC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.60 per share.	Indirecto	2.160.000	07 sept 2022	600.000
GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.98 per share.	Indirecto	18.376.200	16 ago 2022	3.690.000
ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.98 per share.	Indirecto	18.376.200	16 ago 2022	3.690.000
LU HONGBO B Director	Purchase at price 2.98 - 4.98 per share.	Indirecto	10.821.962	16 ago 2022	2.624.239
VIVO OPPORTUNITY LLC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 2.98 - 4.98 per share.	Indirecto	10.821.962	16 ago 2022	2.624.239
YOON SEOKHO BRYAN Chief Operating Officer	Purchase at price 1.47 per share.	Directo	11.254	31 may 2022	7.656
VIGNOLA MARK J. Chief Financial Officer	Purchase at price 1.47 per share.	Directo	11.254	31 may 2022	7.656
GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 17.00 per share.	Indirecto	8.075.000	09 feb 2021	475.000
GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security		Indirecto		09 feb 2021	3.316.204
VIVO CAPITAL VIII, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 17.00 per share.	Indirecto	8.075.000	09 feb 2021	475.000
VIVO CAPITAL VIII, L.L.C. Beneficial Owner of more than 10% of a Class of Security		Indirecto		09 feb 2021	2.200.133
ORBIMED ADVISORS, L.L.C. Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 17.00 per share.	Indirecto	8.075.000	09 feb 2021	475.000
ORBIMED ADVISORS, L.L.C. Director and Beneficial Owner of more than 10% of a Class of Security		Indirecto		09 feb 2021	3.316.204
FLYNN JAMES E Beneficial Owner of more than 10% of a Class of Security	Purchase at price 17.00 per share.	Indirecto	11.305.000	09 feb 2021	665.000
FLYNN JAMES E Beneficial Owner of more than 10% of a Class of Security		Indirecto		09 feb 2021	1.717.033
LAV BIOSCIENCES FUND V LP Beneficial Owner of more than 10% of a Class of Security		Indirecto		09 feb 2021	4.781.566

IBEX 3511.246,00-65,10(-0,58%)

Euro Stoxx 505.035,41-2,19(-0,04%)

Dólar/Euro1,0850+0,0032(+0,29%)

Petróleo Brent82,16+0,80(+0,98%)

Oro2.335,20-2,00(-0,09%)

Bitcoin EUR63.231,08+820,15(+1,31%)

Terns Pharmaceuticals, Inc. (TERN)

Transacciones de accionistas miembros de la empresa

Transacciones comunicadas por la persona con información privilegiada: últimos dos años

IBEX 35
11.246,00
-65,10(-0,58%)

Euro Stoxx 50
5.035,41
-2,19(-0,04%)

Dólar/Euro
1,0850
+0,0032(+0,29%)

Petróleo Brent
82,16
+0,80(+0,98%)

Oro
2.335,20
-2,00(-0,09%)

Bitcoin EUR
63.231,08
+820,15(+1,31%)